These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9226004)

  • 41. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
    J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
    Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
    J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.
    Geleziunas R; Arts EJ; Boulerice F; Goldman H; Wainberg MA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1305-12. PubMed ID: 8392310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of 3'-azido-3'-deoxythymidine metabolites on simian virus 40 origin-dependent replication and heteroduplex repair in HeLa cell extracts.
    Bebenek K; Thomas DC; Roberts JD; Eckstein F; Kunkel TA
    Mol Pharmacol; 1993 Jan; 43(1):57-63. PubMed ID: 8380884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS.
    Klinman DM; Krieg A; Conover J; Ussery MA; Black PL
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):101-6. PubMed ID: 1310603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus.
    Franchetti P; Abu Sheikha G; Cappellacci L; Marchetti S; Grifantini M; Balestra E; Perno C; Benatti U; Brandi G; Rossi L; Magnani M
    Antiviral Res; 2000 Sep; 47(3):149-58. PubMed ID: 10974367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NMR study of dideoxynucleotides with anti-human immunodeficiency virus (HIV) activity.
    Reddy DV; Jagannadh B; Kunwar AC
    J Biochem Biophys Methods; 1996 Feb; 31(3-4):113-21. PubMed ID: 8675954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ZDV delays but does not prevent the transmission of MAIDS by LP-BM5 MuLV-infected macrophage-monocytes.
    Bilello JA; Kort JJ; MacAuley C; Fredrickson TN; Yetter RA; Eiseman JL
    J Acquir Immune Defic Syndr (1988); 1992; 5(6):571-6. PubMed ID: 1316959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular thymidine kinase activity is required for the inhibition of HIV-1 replication by AZT in lymphocytes.
    Lowy I; Caruso M; Goff SP; Klatzmann D
    Virology; 1994 Apr; 200(1):271-5. PubMed ID: 8128627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
    Buckheit RW; Germany-Decker J; Hollingshead MG; Allen LB; Shannon WM; Janssen PA; Chirigos MA
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1097-106. PubMed ID: 7508723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate.
    Lefebvre I; Périgaud C; Pompon A; Aubertin AM; Girardet JL; Kirn A; Gosselin G; Imbach JL
    J Med Chem; 1995 Sep; 38(20):3941-50. PubMed ID: 7562927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AZT-5'-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agent.
    Jan ST; Zhu Z; Tai HL; Shih MJ; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Jan; 10(1):47-52. PubMed ID: 10079879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphate derivatives of AZT display enhanced selectivity of action against HIV 1 by comparison to the parent nucleoside.
    McGuigan C; Nickson C; Petrik J; Karpas A
    FEBS Lett; 1992 Sep; 310(2):171-4. PubMed ID: 1397268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro.
    Molema G; Jansen RW; Pauwels R; de Clercq E; Meijer DK
    Biochem Pharmacol; 1990 Dec; 40(12):2603-10. PubMed ID: 1979734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.
    Meyer PR; Matsuura SE; Zonarich D; Chopra RR; Pendarvis E; Bazmi HZ; Mellors JW; Scott WA
    J Virol; 2003 Jun; 77(11):6127-37. PubMed ID: 12743270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Greatly enhanced inhibition of human immunodeficiency virus type 1 replication in CEM and HT4-6C cells by 3'-deoxythymidine diphosphate dimyristoylglycerol, a lipid prodrug of 3'-deoxythymidine.
    Hostetler KY; Richman DD; Carson DA; Stuhmiller LM; van Wijk GM; van den Bosch H
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2025-9. PubMed ID: 1416896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors.
    Tramontano E; Marongiu ME; de Montis A; Loi AG; Artico M; Massa S; Mai A; la Colla P
    New Microbiol; 1994 Oct; 17(4):269-79. PubMed ID: 7532270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level.
    Mentel R; Kurek S; Wegner U; Janta-Lipinski M; Gürtler L; Matthes E
    Med Microbiol Immunol; 2000 Nov; 189(2):91-5. PubMed ID: 11138642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoglycoproteins as carriers for antiviral drugs: synthesis and analysis of protein-drug conjugates.
    Molema G; Jansen RW; Visser J; Herdewijn P; Moolenaar F; Meijer DK
    J Med Chem; 1991 Mar; 34(3):1137-41. PubMed ID: 2002455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.